So you'd rather them say nothing while the share price dwindles even further for the two months or so it may take to have a completed/initiated PR? After two years of holds and misery? You'd rather only the 6,000 people (not an exact number) who are aware of Cytodyn be the only ones who know anything about it's progress? You don't want the investors in the company's that have these other drugs to hear about this upcoming trial in case they'd like to toss some money at it?

I mean, I get it. Yes, I'd prefer a PR that they've launched the trial or gotten approval to launch. And boy do I wish we were closer to launching this thing. But in lieu of that, this is a very nice step in the direction of better communication with investors and the market.

Also, in reading the PR it's pretty clear this is a complicated AF kind of trial to run, and I'd prefer they get it right so I don't mind the back and forth here as much as I minded the surprise protocols and HIV shit the FDA made us go through.